Dare Bioscience, Inc. (DARE)
$0.72-$0.02 (-2.52%) Today
Latest DARE Insider Trades
Jessica D. Grossman - DirectorGrant or award26,066 sh
Jessica D. Grossman - Director
Susan L. Kelley - Director
Gregory W. Matz - Director
William H. Rastetter - Director
Robin Joan Steele - DirectorWilliam H. Rastetter - DirectorSusan L. Kelley - DirectorRobin Joan Steele - DirectorDare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 10 | 195,969 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
19 Form 4 filings on record, the earliest from Jul 9, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jessica D. Grossman - Director | Grant or award | Common stock | 26,066 | $0.00 | - | |
| Susan L. Kelley - Director | Grant or award | Common stock | 23,696 | $0.00 | - | |
| Gregory W. Matz - Director | Grant or award | Common stock | 30,805 | $0.00 | - | |
| William H. Rastetter - Director | Grant or award | Common stock | 38,862 | $0.00 | - | |
| Robin Joan Steele - Director | Grant or award | Common stock | 26,540 | $0.00 | - | |
| William H. Rastetter - Director | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Susan L. Kelley - Director | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Robin Joan Steele - Director | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Gregory W. Matz - Director | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Jessica D. Grossman - Director | Grant or award | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Sabrina Martucci Johnson - Officer | Grant or award | Series A Convertible Preferred Stock | 10,800 | - | - | |
| Sabrina Martucci Johnson - Officer | Grant or award | Common Stock Warrant (right to buy) | 21,600 | - | - | |
| Sabrina Martucci Johnson - Officer | Grant or award | Employee Stock Option (right to buy) | 172,000 | $0.00 | - | |
 Mardee Haring-Layton - Officer | Grant or award | Employee Stock Option (right to buy) | 49,000 | $0.00 | - | |
| Mardee Haring-Layton - Officer | Grant or award | Employee Stock Option (right to buy) | 57,000 | $0.00 | - | |
| Jessica D. Grossman - Director | Grant or award | Stock Option (right to buy) | 4,500 | $0.00 | - | |
| Robin Joan Steele - Director | Grant or award | Stock Option (right to buy) | 4,500 | $0.00 | - | |
| Gregory W. Matz - Director | Grant or award | Stock Option (right to buy) | 4,500 | $0.00 | - | |
| Susan L. Kelley - Director | Grant or award | Stock Option (right to buy) | 4,500 | $0.00 | - | |
| William H. Rastetter - Director | Grant or award | Stock Option (right to buy) | 4,500 | $0.00 | - |
Dare Bioscience, Inc. (DARE) had 10 insider filings in the last 90 days, with the most recent on 2026-07-02. The full record for DARE runs to 19 Form 4 filings, the earliest from 2025-07-09. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of DARE were filed in the last 90 days.
No insider sales of DARE were filed in the last 90 days.
This page tracks DARE Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add DARE to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
